We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.
For more information visit our privacy policy.Common Contracts
2 similar Co-Exclusive Sublicense Agreement contracts by TrovaGene Inc.
EX-10.6 5 a11-28276_4ex10d6.htm EX-10.6 CO-EXCLUSIVE SUBLICENSE AGREEMENTCo-Exclusive Sublicense Agreement • May 5th, 2020 • Delaware
THIS CO-EXCLUSIVE SUBLICENSE AGREEMENT (“Agreement”) effective as of the date of last signature below (the “Effective Date”) is by and between XENOMICS, Inc., a Florida corporation having its principal office at 420 Lexington Avenue Suite 1701 New York, NY 10170 USA, United States of America (“XENOMICS”) and ASURAGEN, Inc., a Delaware corporation having its principal office at 2150 Woodward, Suite 100, Austin, TX 78744 (“ASURAGEN”).
Standard Contracts
CO-EXCLUSIVE SUBLICENSE AGREEMENTCo-Exclusive Sublicense Agreement • February 15th, 2012 • TrovaGene Inc. • Biological products, (no disgnostic substances) • Delaware
THIS CO-EXCLUSIVE SUBLICENSE AGREEMENT (“Agreement”) effective as of the date of last signature below (the “Effective Date”) is by and between XENOMICS, Inc., a Florida corporation having its principal office at 420 Lexington Avenue Suite 1701 New York, NY 10170 USA, United States of America (“XENOMICS”) and ASURAGEN, Inc., a Delaware corporation having its principal office at 2150 Woodward, Suite 100, Austin, TX 78744 (“ASURAGEN”).